[ET Net News Agency, 6 November 2019] China Medical System Holdings Limited (00867)
said the group through its wholly-owned subsidiary signed a license agreement with Sun
Pharma Advanced Research Company Ltd. (SPARC) for five innovative products.
According to the Agreement, the group through its wholly-owned subsidiary will gain an
exclusive license with the right to grant sublicenses under SPARC's intellectual property
rights and regulatory documentation to develop and commercialise the products in Greater
China.
The initial term of the agreement shall be 20 years from the first commercial sale of
the products in the territory and may be extended for additional 3 years increments if the
wholly owned subsidiary of the group meets certain conditions defined in the agreement.
(RC)